South & Central America Tracheostomy Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Tracheostomy Tubes, Tracheostomy Ventilation Accessories, Tracheostomy Clean and Care Kits, and O
Description
The tracheostomy market in South and Central America was valued at approximately US$ 65.01 million in 2023 and is projected to grow to US$ 100.43 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2023 to 2031. This growth is significantly driven by the increasing geriatric population in the region, which is associated with a rise in respiratory diseases and a consequent demand for tracheostomy procedures.
As individuals age, they often experience a decline in lung function and an increased vulnerability to various respiratory conditions. The elderly population is particularly susceptible to chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and other respiratory ailments. Globally, the aging population is on the rise; according to the World Health Organization (WHO), by 2030, one in six people will be aged 60 years or older, with the number of older adults expected to reach 1.4 billion by 2030 and 2.1 billion by 2050, up from 1 billion in 2020. Notably, the WHO also projects that by 2050, 80% of older individuals will reside in low- and middle-income countries. In South and Central America, the United Nations Economic Commission for Latin America and the Caribbean (ECLAC) reported that in 2022, there were 88.6 million people aged 60 and above, representing 13.4% of the total population. This figure is anticipated to increase to 16.5% by 2030, underscoring the demographic shift towards an aging population in the region. This trend is a primary driver of growth in the tracheostomy market.
The South and Central America tracheostomy market is experiencing an uptick in the number of procedures performed, largely due to the rising incidence of critical care patients, especially those suffering from respiratory conditions. This surge in demand directly influences the market by increasing the need for tracheostomy equipment, accessories, and related care services. For instance, the International Agency for Research on Cancer (IARC) reported that Brazil alone had 44,213 new lung cancer cases in 2022. The growing prevalence of chronic respiratory diseases, particularly among the aging population in Brazil, is expected to maintain a steady demand for tracheostomy procedures, thereby supporting market growth in the years to come.
Market Segmentation Overview
The South and Central America tracheostomy market can be segmented based on type, technique, end user, and country.
1. Type: The market is divided into several categories, including tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy cleaning and care kits. Among these, the tracheostomy tubes segment held the largest market share in 2023, reflecting their essential role in the procedure.
2. Technique: The market is further bifurcated into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment accounted for a larger share of the market in 2023, likely due to its minimally invasive nature and associated benefits.
3. End User: The market is categorized by end users, including hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutions. In 2023, hospitals and surgery centers represented the largest segment, indicating that most tracheostomy procedures are performed in these settings.
4. Country: The market is segmented into Brazil, Argentina, and the rest of South and Central America. Brazil emerged as the dominant player in the tracheostomy market in 2023, driven by its large population and significant healthcare infrastructure.
Strategic Insights and Company Profiles
Several key players are actively operating in the South and Central America tracheostomy market, including AdvaCare Pharma USA LLC, Andreas Fahl Medizintechnik-Vertrieb GmbH, Angiplast, Boston Medical Products Inc, Coloplast Corp, Cook Medical Holdings LLC, Fisher & Paykel Healthcare Corp Ltd, Fuji Systems Corporation, ICU Medical Inc, Intersurgical Ltd, Kapitex Healthcare Limited, Medtronic Plc, SunMed Group Holdings LLC (AirLife), Teleflex Inc, Tianjin Medis Medical Device Co. Ltd., Troge Medical GmbH, VBM Medizintechnik GmbH, and Well Lead Medical Co. Ltd. These companies are pivotal in providing innovative products and solutions that cater to the growing needs of the tracheostomy market in the region.
In conclusion, the South and Central America tracheostomy market is poised for significant growth, driven by demographic changes and an increasing prevalence of respiratory diseases among the aging population. The market's expansion is supported by advancements in medical technology and a growing awareness of the importance of respiratory care.
As individuals age, they often experience a decline in lung function and an increased vulnerability to various respiratory conditions. The elderly population is particularly susceptible to chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and other respiratory ailments. Globally, the aging population is on the rise; according to the World Health Organization (WHO), by 2030, one in six people will be aged 60 years or older, with the number of older adults expected to reach 1.4 billion by 2030 and 2.1 billion by 2050, up from 1 billion in 2020. Notably, the WHO also projects that by 2050, 80% of older individuals will reside in low- and middle-income countries. In South and Central America, the United Nations Economic Commission for Latin America and the Caribbean (ECLAC) reported that in 2022, there were 88.6 million people aged 60 and above, representing 13.4% of the total population. This figure is anticipated to increase to 16.5% by 2030, underscoring the demographic shift towards an aging population in the region. This trend is a primary driver of growth in the tracheostomy market.
The South and Central America tracheostomy market is experiencing an uptick in the number of procedures performed, largely due to the rising incidence of critical care patients, especially those suffering from respiratory conditions. This surge in demand directly influences the market by increasing the need for tracheostomy equipment, accessories, and related care services. For instance, the International Agency for Research on Cancer (IARC) reported that Brazil alone had 44,213 new lung cancer cases in 2022. The growing prevalence of chronic respiratory diseases, particularly among the aging population in Brazil, is expected to maintain a steady demand for tracheostomy procedures, thereby supporting market growth in the years to come.
Market Segmentation Overview
The South and Central America tracheostomy market can be segmented based on type, technique, end user, and country.
1. Type: The market is divided into several categories, including tracheostomy tubes, tracheostomy ventilation accessories, other accessories, and tracheostomy cleaning and care kits. Among these, the tracheostomy tubes segment held the largest market share in 2023, reflecting their essential role in the procedure.
2. Technique: The market is further bifurcated into surgical tracheostomy and percutaneous dilatational tracheostomy. The percutaneous dilatational tracheostomy segment accounted for a larger share of the market in 2023, likely due to its minimally invasive nature and associated benefits.
3. End User: The market is categorized by end users, including hospitals and surgery centers, ambulatory care centers, home care settings, and research laboratories and academic institutions. In 2023, hospitals and surgery centers represented the largest segment, indicating that most tracheostomy procedures are performed in these settings.
4. Country: The market is segmented into Brazil, Argentina, and the rest of South and Central America. Brazil emerged as the dominant player in the tracheostomy market in 2023, driven by its large population and significant healthcare infrastructure.
Strategic Insights and Company Profiles
Several key players are actively operating in the South and Central America tracheostomy market, including AdvaCare Pharma USA LLC, Andreas Fahl Medizintechnik-Vertrieb GmbH, Angiplast, Boston Medical Products Inc, Coloplast Corp, Cook Medical Holdings LLC, Fisher & Paykel Healthcare Corp Ltd, Fuji Systems Corporation, ICU Medical Inc, Intersurgical Ltd, Kapitex Healthcare Limited, Medtronic Plc, SunMed Group Holdings LLC (AirLife), Teleflex Inc, Tianjin Medis Medical Device Co. Ltd., Troge Medical GmbH, VBM Medizintechnik GmbH, and Well Lead Medical Co. Ltd. These companies are pivotal in providing innovative products and solutions that cater to the growing needs of the tracheostomy market in the region.
In conclusion, the South and Central America tracheostomy market is poised for significant growth, driven by demographic changes and an increasing prevalence of respiratory diseases among the aging population. The market's expansion is supported by advancements in medical technology and a growing awareness of the importance of respiratory care.
Table of Contents
137 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
